Pharmaceutical Company Pays $25 Million To Resolve Alleged False Claims Act Liability For Price-Fixing Of Generic Drug
PHILADELPHIA – United States Attorney Jacqueline C. Romero announced that Glenmark Pharmaceuticals Inc., USA, a generic pharmaceutical manufacturer located in Mahwah, New Jersey, has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug.
More About This Action
Action Details
- Date:September 4, 2024
- Agency:U.S. Department of Justice and U.S. Attorney's Office, Eastern District of Pennsylvania
-
Enforcement Types:
- Criminal and Civil Actions